Mega Genomics Limited reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was CNY 151.3 million compared to CNY 145.73 million a year ago. Net income was CNY 30.04 million compared to net loss of CNY 17.62 million a year ago.

Basic earnings per share from continuing operations was CNY 0.14 compared to basic loss per share from continuing operations of CNY 0.09 a year ago.